pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,237 catalysts · 5,539 phase readout · 2,316 8k filing · 379 pdufa · 241 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 68 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 1 catalyst2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,539
  • 8k filing2,316
  • pdufa379
  • earnings241
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Week of Aug 3, 2026

44
›Aug 4, 20268k filing1d ago$IBIO — iBio, Inc. (IBIO) — 8-K filing

Items: 5.02, 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$BEAM — Beam Therapeutics Inc. (BEAM) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$LRMR — Larimar Therapeutics, Inc. (LRMR) — 8-K filing

Items: 2.02, 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$ODTX — Odyssey Therapeutics, Inc. (ODTX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$BCRX — BIOCRYST PHARMACEUTICALS INC (BCRX) — 8-K filing

Items: 2.05

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$TELA — TELA Bio, Inc. (TELA) — 8-K filing

Items: 5.02

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$MRK — Merck & Co., Inc. (MRK) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$PFE — PFIZER INC (PFE) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$ZEOX — Zeo ScientifiX, Inc. (ZEOX) — 8-K filing

Items: 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$PVLA — PALVELLA THERAPEUTICS, INC. (PVLA) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$TOVX — Theriva Biologics, Inc. (TOVX) — 8-K filing

Items: 5.02, 5.07, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$RYTM — RHYTHM PHARMACEUTICALS, INC. (RYTM) — 8-K filing

Items: 2.02, 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$CRVO — CervoMed Inc. (CRVO) — 8-K filing

Items: 7.01, 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$IBRX — ImmunityBio, Inc. (IBRX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$RANI — Rani Therapeutics Holdings, Inc. (RANI) — 8-K filing

Items: 5.02

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$FTH — Faeth Therapeutics, Inc. (FTH) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$GALT — GALECTIN THERAPEUTICS INC (GALT) — 8-K filing

Items: 3.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$HRMY — Harmony Biosciences Holdings, Inc. (HRMY) — 8-K filing

Items: 2.02, 7.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$BAX — BAXTER INTERNATIONAL INC (BAX) — 8-K filing

Items: 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$EOLS — Evolus, Inc. (EOLS) — 8-K filing

Items: 1.01, 7.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d agoHepion Pharmaceuticals, Inc. (HEPA, CTRVP) — 8-K filing

Items: 1.01, 3.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$NVCT — Nuvectis Pharma, Inc. (NVCT) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$JNJ — JOHNSON & JOHNSON (JNJ) — 8-K filing

Items: 5.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$DNTH — Dianthus Therapeutics, Inc. /DE/ (DNTH) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$SYRE — Spyre Therapeutics, Inc. (SYRE) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$PCRX — Pacira BioSciences, Inc. (PCRX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$PRCT — PROCEPT BioRobotics Corp (PRCT) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$OTLC — Oncotelic Therapeutics, Inc. (OTLC) — 8-K filing

Items: 1.01, 2.03, 3.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$RNXT — RenovoRx, Inc. (RNXT) — 8-K filing

Items: 8.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$TVTX — Travere Therapeutics, Inc. (TVTX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$KIDS — ORTHOPEDIATRICS CORP (KIDS) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$ATEC — Alphatec Holdings, Inc. (ATEC) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$ACAD — ACADIA PHARMACEUTICALS INC (ACAD) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$OKUR — OnKure Therapeutics, Inc. (OKUR) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$RARE — Ultragenyx Pharmaceutical Inc. (RARE) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$TYRA — Tyra Biosciences, Inc. (TYRA) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$MCRB — Seres Therapeutics, Inc. (MCRB) — 8-K filing

Items: 1.01, 1.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$SNDX — Syndax Pharmaceuticals Inc (SNDX) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d agoSilexion Therapeutics Corp (SLXN, SLXNW) — 8-K filing

Items: 7.01, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$RIGL — RIGEL PHARMACEUTICALS INC (RIGL) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$PGEN — PRECIGEN, INC. (PGEN) — 8-K filing

Items: 2.02

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$GILD — GILEAD SCIENCES, INC. (GILD) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$ARWR — ARROWHEAD PHARMACEUTICALS, INC. (ARWR) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗
›Aug 4, 20268k filing1d ago$AMGN — AMGEN INC (AMGN) — 8-K filing

Items: 2.02, 9.01

full page →edgar 8k ↗

Week of Jan 4, 2027

1
›Jan 4, 2027pdufa152dPDUFA — 2027-01-04

action date of January 4, 2027

full page →pdufa extract ↗

Week of Jan 18, 2027

1
›Jan 21, 2027pdufa169dPDUFA — 2027-01-21Ultragenyx Pharmaceutical Inc.

action date of Jan. 21, 2027

full page →pdufa extract ↗

Date TBD

4
›TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗
›TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗
›RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

full page →ctgov ↗
← prev
page 54 of 165
next →
$ABBV245.10-2.33%
$RARE25.39+1.48%
$NVS153.16-0.33%